Synonyms: SPM-8272 | SPM-907 | Toviaz®
fesoterodine is an approved drug (EMA (2007), FDA (2008))
Compound class:
Synthetic organic
Comment: The marketed formulation contains the fumarate compound (PubChem CID 9849808). Fesoterodine is an antimuscarinic prodrug, with the active metabolite being 5-hydroxymethyl tolterodine (5-HMT, PubChem CID 9819382).
View more information in the IUPHAR Pharmacology Education Project: fesoterodine |
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (EMA (2007), FDA (2008)) |
IUPAC Name |
[2-[(1R)-3-(di(propan-2-yl)amino)-1-phenylpropyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate |
International Nonproprietary Names | |
INN number | INN |
8068 | fesoterodine |
Synonyms |
SPM-8272 | SPM-907 | Toviaz® |
Database Links | |
CAS Registry No. | 286930-03-8 |
ChEMBL Ligand | CHEMBL1201764 |
DrugBank Ligand | DB06702 |
DrugCentral Ligand | 4191, 4191 |
GtoPdb PubChem SID | 187051776 |
PubChem CID | 6918558 |
Search Google for chemical match using the InChIKey | DCCSDBARQIPTGU-HSZRJFAPSA-N |
Search Google for chemicals with the same backbone | DCCSDBARQIPTGU |
Search PubMed clinical trials | fesoterodine |
Search PubMed titles | fesoterodine |
Search PubMed titles/abstracts | fesoterodine |
UniChem Compound Search for chemical match using the InChIKey | DCCSDBARQIPTGU-HSZRJFAPSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | DCCSDBARQIPTGU-HSZRJFAPSA-N |
Wikipedia | Fesoterodine |